Washington, DC – US President Donald Trump said that the tariffs he imposed during his term have prompted the Swiss pharmaceutical giant Novartis to expand its operations in the United States, calling it “clear evidence of the success of his trade policies.”
In remarks reported by US media, Trump added that imposing strict tariffs on a number of imports was intended to bring investment and jobs back to the US. He also noted that major companies were forced to reassess their strategies and move some of their production or expand their factories within the US market.
Novartis is one of the world’s largest pharmaceutical companies and has a significant presence in the US market, which is one of its largest markets in terms of sales and research and development.
Analysts believe Trump’s remarks are part of his ongoing defense of his “America First” economic approach. They point to this particularly as the debate intensifies within the US regarding the impact of tariffs on prices and supply chains.
Conversely, critics of the tariff policy argue that its effect has been twofold. While it has attracted some investment, it has also increased production costs for American companies that rely on imported components. This has sparked a broader debate about the cost versus the benefits of protectionism.
